Hormone Signaling: Receptors, Second Messengers, and Pathways

Overview of Hormone Signaling

• Hormones act as chemical messengers; communication system between cells via chemical signals.

• Modes of signaling discussed: endocrine, paracrine, autocrine (briefly referenced as part of how signals travel).

• The focus: how target cells receive and respond to the signal, i.e., receptor binding and downstream effects.

• Binding is essential: if the hormone does not bind its receptor, no cellular response occurs.

• Target cells must have specific receptors for a given hormone (e.g., insulin receptors for insulin).

• Receptors are proteins; binding is often described as a lock-and-key fit.

• Receptor location matters: some receptors are membrane-bound (outside the cell) and some are intracellular (inside the cell).

• Lipid solubility of the hormone determines receptor location and signaling strategy.

Receptors and Signal Reception

• If the receptor is membrane-bound (outside the cell): the hormone binds to the receptor on the plasma membrane; signaling occurs across the membrane.

• If the receptor is intracellular (inside the cell): the hormone must diffuse across the plasma membrane to bind the receptor.

• Location of receptor matters because it determines whether signaling uses second messengers or direct gene activation.

Lipid-Soluble vs Lipid-Insulation: Receptors by Hormone Type

• Lipid-soluble hormones (lipids) can diffuse across the plasma membrane and bind intracellular receptors.

• Major lipid-soluble hormone categories mentioned:

  • Steroids (definitely diffuse across membranes; direct gene activation).

  • Eicosanoids (derived from phospholipids; typically lipid-soluble, but functionally distinct; can involve other signaling mechanisms; more nuance discussed below).

• Lipid-insoluble (water-soluble) hormones cannot diffuse across the membrane and have receptors on the plasma membrane; signaling relies on second messengers inside the cell.

• Amino acid-based hormones (and many eicosanoids) are water-soluble and bind membrane receptors; signaling usually uses second messengers.

• The hormone receptor complex can stay on or in the membrane and often undergoes a conformational shift to propagate the signal.

Two Major Pathways for Lipid-Insensitive Hormones (Amino Acid-Based Hormones and Eicosanoids)

• These hormones cannot cross the plasma membrane by simple diffusion and rely on second messenger systems.

• Common pathway type: G protein-coupled receptor (GPCR) signaling with second messengers.

• The hormone (first messenger) binds membrane receptor, forming a hormone–receptor complex; binding causes a conformational change.

• The conformational change allows interaction with a nearby G protein (guanylate nucleotide-binding protein).

• The G protein needs energy to function: GTP binds to the G protein, GDP leaves, activating the G protein.

• The activated G protein then stimulates an enzyme in the membrane (the effector).

• In the cyclic AMP (cAMP) pathway, the effector is adenylate cyclase.

• Adenylate cyclase converts ATP to cyclic AMP (cAMP), which acts as the second messenger inside the cell.

• The second messenger (cAMP) activates protein kinases, which phosphorylate target proteins, leading to cellular responses.

• The hormone itself remains outside the cell; signaling is relay-mediated by the second messenger.

• If signaling continues (hormone remains in extracellular fluid), the receptor can bind again and continue signaling until diffusion away or enzymatic degradation occurs (as with acetylcholine).

Cyclic AMP (cAMP) Second Messenger Pathway (Amino Acid-Based Hormones)

• Steps summarized:

  • Hormone binds membrane receptor → forms hormone–receptor complex.

  • Complex triggers G protein activation; GTP binds to G protein; GDP leaves.

  • Activated G protein stimulates adenylate cyclase (membrane enzyme).

  • Adenylate cyclase converts ATP to cyclic AMP (cAMP) $ext{ATP} <br>ightarrow ext{cAMP}$

  • cAMP acts as the second messenger; diffuses in cytoplasm.

  • cAMP activates protein kinases; kinases phosphorylate target proteins, leading to responses.

  • Cellular responses can include altering membrane permeability, activating enzymes, stimulating secretion, or promoting mitosis.

• Key concepts:

  • First messenger: the hormone.

  • Second messenger: cyclic AMP (cAMP).

  • Kinases (e.g., protein kinases) phosphorylate substrates; phosphorylation often increases a molecule’s activity or changes its function.

  • Kinases are often depicted with a characteristic icon in diagrams; phosphorylation energizes targets much like ATP energizes reactions.

• Important clarifications:

  • Not all hormones use the same second messenger; AMINO ACID-BASED hormones can use cAMP pathways, among others.

  • The energy currency in the G-protein step is GTP; GDP leaves and is replaced by GTP to keep the cycle going. ATP is used later by adenylate cyclase to make cAMP.

• Practical note about signaling variability:

  • A given hormone can produce one or more cellular responses; a single pathway can trigger multiple downstream outcomes, depending on cell type and context.

The Phospholipase C–IP3/DAG Pathway (PIP2 System) — A Second Major Second Messenger Route

• Another second messenger system involving amino acid-based hormones.

• Shared start with the cAMP pathway:

  • Hormone binds membrane receptor → hormone–receptor complex forms → G protein is activated (GTP binds, GDP leaves).

  • This time, the G protein activates phospholipase C (the effector enzyme) rather than adenylate cyclase.

• Phospholipase C cleaves a membrane phospholipid: $ext{PIP}<em>2 ightarrow ext{DAG} + ext{IP}</em>3$

  • DAG (diacylglycerol) remains in the membrane and helps activate membrane-associated protein kinases.

  • IP3 (inositol triphosphate) diffuses into the cytoplasm and targets the endoplasmic reticulum.

• Calcium as a third messenger:

  • IP3 stimulates the release of Ca^{2+} from the smooth endoplasmic reticulum (ER).

  • Calcium then binds to calmodulin, forming a Ca^{2+}-calmodulin complex, which activates various calcium-dependent processes.

• Outcomes of the DAG/IP3 cascade include:

  • Activation of protein kinases in the membrane or cytoplasm.

  • Opening or closing of ion channels.

  • Stimulation of secretion.

  • Calcium-mediated smooth muscle contraction and other calcium-dependent responses.

• Example of a hormone using this pathway:

  • Oxytocin acts via a similar cascade to stimulate uterine smooth muscle contractions; synthetic form Pitocin used to induce labor.

• Recap of DAG/IP3 signaling:

  • First messenger: hormone binds receptor.

  • G protein activation → phospholipase C activation.

  • PIP2 cleavage to DAG and IP3.

  • DAG activates membrane-associated kinases; IP3 releases Ca^{2+} from ER.

  • Ca^{2+} binds calmodulin to effect downstream responses.

Direct Gene Activation by Steroids (Lipid-Soluble Hormones)

• Steroids are lipid-soluble and can diffuse directly across the plasma membrane into the cell.

• Once inside, steroids bind to intracellular receptors (often in the cytoplasm or nucleus).

• The hormone–receptor complex then acts directly on DNA to regulate transcription and gene expression (no second messenger needed).

• Consequences:

  • Altered production of proteins by changing transcription levels.

  • Longer-lasting effects compared with rapid second messenger signaling.

Five Major Cellular Outcomes of Hormone Signaling (Common Endpoints)

• Altered plasma membrane permeability (via ion channels opening/closing) – affects ion flux.

• Changes in plasma membrane or intracellular protein synthesis – e.g., increased production of enzymes or receptors.

• Activation or inhibition of enzyme systems – modulating catalytic activity.

• Stimulation of secretion – release of hormones, enzymes, neurotransmitters, etc.

• Stimulation of mitosis or cell growth/repair – promoting cell division or tissue maintenance.

• Note: Depending on the hormone and target cell, multiple outcomes can occur simultaneously or in sequence.

Signaling Context: Gatekeepers and Specificity

• Receptors determine sensitivity and specificity of the response; a given hormone binds only to its proper receptor.

• The same hormone can have different effects in different cells depending on receptor type and intracellular signaling machinery.

• The presence of second messengers and signaling cascades allows a single hormone to elicit diverse responses.

Practical Mechanisms and Timecourse (Putting It Together)

• General sequence for amino acid-based hormones (second messenger systems):

  • Hormone → receptor (membrane-bound)

  • Receptor–hormone complex → conformational change → activation of G protein

  • G protein → activates membrane enzyme (adenylyl cyclase or phospholipase C)

  • Enzyme converts substrate (ATP or PIP2) to second messengers (cAMP or DAG/IP3)

  • Second messenger(s) activate kinases or release Ca^{2+} → downstream cellular responses

• Time scales differ:

  • Second messenger cascades tend to be rapid and reversible.

  • Direct gene activation by steroids tends to be slower but longer-lasting.

Insulin Signaling, Insulin Resistance, and Receptors (Clinical Context from Transcript)

• Insulin signaling relies on receptors on the plasma membrane; insulin cannot cross the membrane.

• Insulin resistance (e.g., type 2 diabetes risk) is often discussed in the context of receptor signaling efficiency, not just hormone quantity.

• Leading theory described: membrane receptor signaling can be altered by cell size/shape changes (receptor conformation changes) due to weight gain.

  • If a cell’s receptors change shape or size, insulin binding can be impaired, leading to reduced signaling.

  • Weight loss may help revert receptor conformation toward normal, improving insulin sensitivity.

• Other related points:

  • GLP-1 receptor agonists (e.g., GLP-1 analogs) can aid weight loss and improve insulin sensitivity in some contexts.

  • If pancreatic islets (Islets of Langerhans) are damaged, insulin production declines, leading to dependence on external insulin.

  • Pancreatic anatomy context:

  • Islets of Langerhans produce insulin and glucagon.

  • Pancreatic acinar cells (exocrine pancreas) produce digestive enzymes and fluids; digestive issues can affect islets and hormone production.

  • Pancreatic cancer can impact hormone production and digestion simultaneously.

Pancreas Structure Recap (From Transcript Context)

• Islets of Langerhans: insulin and glucagon production sites within the pancreas.

• Exocrine pancreas: pancreatic acinar cells responsible for digestive enzyme production.

• Interaction of digestive issues with islets may affect hormone production and signaling.

Key Takeaways and Connections

• Hormone signaling relies on receptor presence and localization (membrane vs intracellular).

• Lipid-soluble hormones (steroids, certain others) can directly modulate gene expression; others rely on second messengers to convey signals inside the cell.

• Two central second messenger pathways discussed:

  • cAMP pathway via Gs protein and adenylyl cyclase → cAMP → protein kinases.

  • PIP2 pathway via phospholipase C → DAG and IP3 → Ca^{2+} release → calmodulin, kinases, and downstream effects.

• Calcium acts as a third messenger in the IP3 pathway, enabling rapid, calcium-dependent responses such as secretion or muscle contraction.

• Hormone signaling is a major target for pharmacological intervention; understanding these pathways helps explain how drugs (e.g., insulin therapy, GLP-1 agonists, pitocin) exert their effects.

• Ethical/philosophical angle: signaling pathways illustrate how small molecules can have large-scale physiological effects; precision in targeting receptors and pathways is crucial for safe and effective therapies.

Notation and Equations (Summary for Quick Reference)

• Adenylyl cyclase reaction:

  • $ext{ATP} <br>ightarrow ext{cAMP}$

• PIP2 hydrolysis via phospholipase C:

  • $ext{PIP}<em>2 ightarrow ext{DAG} + ext{IP}</em>3$

• IP3-mediated Ca^{2+} release and downstream calcium signaling:

  • $ext{IP}_3 <br>ightarrow ext{Ca}^{2+} ext{ release from ER}$

  • $ext{Ca}^{2+} + ext{Calmodulin} <br>ightarrow ext{Ca}^{2+} ext{-calmodulin complex}$

• First messenger vs second messenger distinction:

  • First messenger: the hormone outside the cell.

  • Second messengers: intracellular signals (e.g., cAMP, DAG, IP3, Ca^{2+}).

• G protein cycle (conceptual):

  • Hormone–receptor complex activates G protein via GDP/GTP exchange on the G protein.

  • GTP-bound G protein activates membrane effectors (adenylyl cyclase or phospholipase C).

Connections to Previous and Real-World Relevance

• Gatekeeping concepts (lock-and-key receptors) tie back to foundational cellular biology and prior lectures on cell signaling and receptors.

• The second messenger systems connect to broader topics like nervous system signaling (neurotransmitters) and pharmacology (drug targets within signaling pathways).

• Real-world relevance includes understanding diabetes management (insulin therapy, insulin resistance, weight-loss strategies impacting receptor signaling) and obstetric signaling (oxytocin/Pitocin and uterine contractions).

• Practical implications: pharmaceutical design often aims to modulate specific steps in these pathways to achieve therapeutic effects with minimal side effects.